nipradilol has been researched along with propranolol in 19 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 13 (68.42) | 18.7374 |
| 1990's | 4 (21.05) | 18.2507 |
| 2000's | 2 (10.53) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Aramaki, T; Katsuta, Y; Komeichi, H; Kurokawa, H; Ohsuga, M; Okumura, H; Satomura, K; Sekiyama, T; Terada, H; Tsutsui, H | 1 |
| Higuchi, M | 1 |
| Hieda, N; Ito, T; Ogawa, T; Ozawa, T; Satake, T; Sugiyama, S | 1 |
| Fujii, M; Nakamura, M; Shirasawa, Y | 1 |
| Kanno, M; Nakao, Y; Nakaya, H | 1 |
| Kawada, M; Satoh, K; Taira, N | 1 |
| Noguchi, K; Sakanashi, M | 1 |
| Hayashi, K; Iwata, M; Ozawa, T; Sugiyama, S; Taki, F | 1 |
| Fujii, M; Ito, T; Kojima, J; Suzuki, J; Yoshimura, M | 1 |
| Uchida, Y | 1 |
| Higa, T; Ito, H; Miyamato, Y; Noguchi, K; Sakanashi, M; Takeo, S | 1 |
| Hisa, H; Kamijo, T; Satoh, S; Suzuki, M | 1 |
| Kanno, M; Kimura, S; Nakao, Y; Nakaya, H | 1 |
| Kawashima, K; Sokabe, H; Watanabe, TX | 1 |
| Haraoka, S; Kobayashi, H; Maekawa, K; Mizuo, K; Obayashi, N; Saito, D; Uchida, S | 1 |
| Cailmail, S; Lebrec, D; Ohsuga, M | 1 |
| Nakamura, M; Sonoki, H; Takeshita, A | 1 |
| Hasuike, Y; Hiraoka, K; Inoue, T; Itahana, R; Izumi, M; Miyagawa, K; Nakanishi, T; Nishihara, F; Takamitsu, Y | 1 |
| Anttila, V; del Nido, P; Suematsu, Y; Takamoto, S | 1 |
19 other study(ies) available for nipradilol and propranolol
| Article | Year |
|---|---|
Long-term haemodynamic effects of a 4-week regimen of nipradilol, a new beta-blocker with nitrovasodilating properties, in patients with portal hypertension due to cirrhosis. A comparative study with propranolol.
Topics: Adrenergic beta-Antagonists; Adult; Aged; Blood Pressure; Female; Hemodynamics; Humans; Hypertension, Portal; Liver; Liver Cirrhosis; Male; Middle Aged; Propanolamines; Propranolol; Time Factors; Vasodilation; Vasodilator Agents | 1992 |
Participation of the vasodilating property of nipradilol in improving ischemic derangement of myocardial energy metabolism.
Topics: Animals; Blood Pressure; Cardiac Output; Coronary Disease; Coronary Vessels; Dogs; Energy Metabolism; Heart; Heart Rate; Lactates; Male; Myocardium; Phosphates; Phosphocreatine; Propanolamines; Propranolol; Vasodilator Agents | 1989 |
Cardioprotective and antiarrhythmic effects of beta-blockers, propranolol, bisoprolol, and nipradilol in a canine model of regional ischemia.
Topics: Acetylglucosaminidase; Adrenergic beta-Antagonists; Animals; Arrhythmias, Cardiac; Bisoprolol; Coronary Circulation; Coronary Disease; Dogs; Female; Glucuronidase; Heart Failure; Heart Rate; Lysosomes; Male; Mitochondria, Heart; Myocardial Contraction; Myocardial Infarction; Propanolamines; Propranolol; Ventricular Fibrillation | 1989 |
Venodilating action of nipradilol (K-351) in the pithed rat pretreated with dihydroergotamine.
Topics: Adrenergic alpha-Antagonists; Animals; Decerebrate State; Dihydroergotamine; Hemodynamics; Hydralazine; Male; Propanolamines; Propranolol; Rats; Rats, Inbred Strains; Time Factors; Vasodilator Agents | 1985 |
[Effects of nipradilol, a new beta-blocker, and its metabolite, denitro-nipradilol, on heart rate and AV conduction in anesthetized dogs].
Topics: Adrenergic beta-Antagonists; Animals; Atrioventricular Node; Blood Pressure; Bundle of His; Dogs; Female; Heart Conduction System; Heart Rate; Male; Propanolamines; Propranolol; Sinoatrial Node | 1986 |
Cardiohemodynamic effects of nipradilol (K-351) in the dog: comparison with propranolol, nadolol and prazosin.
Topics: Adrenergic beta-Antagonists; Animals; Dogs; Dose-Response Relationship, Drug; Female; Hemodynamics; Male; Nadolol; Prazosin; Propanolamines; Propranolol | 1986 |
Effects of nipradilol on myocardial ischaemia produced by coronary stenosis in dogs.
Topics: Adrenergic alpha-Antagonists; Animals; Cardiac Pacing, Artificial; Coronary Disease; Dogs; Female; Hemodynamics; Lactates; Lactic Acid; Male; Myocardium; Propanolamines; Propranolol | 1987 |
Effect of nipradilol, a new beta-blocker, on leukotriene D4-induced contraction in guinea pig tracheal smooth muscle.
Topics: Adrenergic beta-Antagonists; Animals; Cyclic GMP; Dose-Response Relationship, Drug; Guinea Pigs; In Vitro Techniques; Isosorbide Dinitrate; Leukotriene B4; Male; Muscle Contraction; Muscle Relaxation; Muscle, Smooth; Propanolamines; Propranolol; Trachea | 1988 |
Pharmacokinetics of nipradilol (K-351), a new antihypertensive agent. II. Influence of the route of administration on bioavailability in dogs.
Topics: Administration, Oral; Animals; Antihypertensive Agents; Biological Availability; Dogs; Injections, Intravenous; Kinetics; Male; Portal Vein; Propanolamines; Propranolol | 1985 |
Cardiovascular effect of [3,4-dihydro-8-(2-hydroxy-3-isopropylaminopropoxy)-3-nitrato-2H-1-benzopyran] (K 351).
Topics: Adrenergic beta-Antagonists; Animals; Blood Pressure; Coronary Circulation; Dogs; Hemodynamics; Myocardial Contraction; Propanolamines; Propranolol; Vascular Resistance | 1982 |
Effects of an antihypertensive agent, nipradilol, on isolated coronary artery of the dog.
Topics: Adrenergic beta-Antagonists; Animals; Antihypertensive Agents; Coronary Vessels; Dogs; Female; In Vitro Techniques; Male; Muscle Contraction; Muscle, Smooth, Vascular; Nitroglycerin; Norepinephrine; Potassium; Propanolamines; Propranolol | 1984 |
Effects of K-351 on hemodynamics and renin release in anesthetized dogs.
Topics: Adrenergic alpha-Antagonists; Anesthesia; Animals; Blood Pressure; Dogs; Female; Heart Rate; Hemodynamics; Indomethacin; Male; Propanolamines; Propranolol; Radioimmunoassay; Renal Circulation; Renin; Splanchnic Circulation; Vascular Resistance | 1984 |
Effects of nipradilol (K-351) on the electrophysiological properties of canine cardiac tissues: comparison with propranolol and sotalol.
Topics: Action Potentials; Adrenergic alpha-Antagonists; Adrenergic beta-Antagonists; Animals; Anti-Arrhythmia Agents; Dogs; Female; Heart; In Vitro Techniques; Male; Propanolamines; Propranolol; Purkinje Fibers; Refractory Period, Electrophysiological; Sotalol | 1984 |
Pharmacodynamic and pharmacokinetic studies on prizidilol and nipradilol (K-351), antihypertensive drugs with combined vasodilator and beta-adrenoceptor blocking actions, in rabbits.
Topics: Adrenergic beta-Antagonists; Angiotensin II; Animals; Antihypertensive Agents; Blood Pressure; Heart Rate; Hydralazine; Isoproterenol; Kinetics; Male; Propanolamines; Propranolol; Pyridazines; Rabbits; Time Factors; Vasodilator Agents | 1984 |
Effects of nipradilol on venous hemodynamics: evaluation with a Doppler blood flow method.
Topics: Adult; Echocardiography, Doppler; Hemodynamics; Humans; Male; Propanolamines; Propranolol; Respiration | 1994 |
Hemodynamic effects of nipradilol, a new beta-adrenergic antagonist combined with a nitroxy base, in rats with intra- or extra-hepatic portal hypertension.
Topics: Adrenergic beta-Antagonists; Animals; Blood Circulation; Hemodynamics; Hypertension, Portal; Male; Pharmaceutical Vehicles; Propanolamines; Propranolol; Rats; Rats, Sprague-Dawley; Splanchnic Circulation | 1993 |
Nipradilol, a new beta-adrenergic blocker, reduces left ventricular remodeling following myocardial infarction in spontaneously hypertensive rats.
Topics: Adrenergic beta-Antagonists; Animals; Captopril; Dilatation, Pathologic; Heart Ventricles; Hemodynamics; Male; Myocardial Infarction; Myocardium; Propanolamines; Propranolol; Rats; Rats, Inbred SHR; Ventricular Function, Left; Ventricular Pressure | 1997 |
A nitric oxide-generating beta-blocking agent prevents renal injury in the rat remnant kidney model. Comparative study of two beta-blocking drugs, nipradilol and propranolol.
Topics: Adrenergic beta-Antagonists; Animals; Cyclic GMP; Enzyme Inhibitors; Hypertension; Kidney; Kidney Diseases; Kidney Glomerulus; Male; Nephrectomy; NG-Nitroarginine Methyl Ester; Nitrates; Nitric Oxide; Nitric Oxide Donors; Nitric Oxide Synthase; Nitrites; Propanolamines; Propranolol; Proteinuria; Rats; Rats, Inbred F344; Renin | 2003 |
Cardioprotection afforded by ischemic preconditioning interferes with chronic beta-blocker treatment.
Topics: Adrenergic beta-Antagonists; Animals; Blood Pressure; Chronic Disease; Contraindications; Heart Ventricles; Ischemic Preconditioning; Lipid Peroxidation; Male; Myocardial Ischemia; Myocardial Reperfusion; Nitric Oxide; Propanolamines; Propranolol; Random Allocation; Rats; Rats, Wistar; Safety | 2004 |